multi-analyte data analysis reduces false positives in ......• crms: 7 • carriers: 29 • total...
TRANSCRIPT
![Page 1: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/1.jpg)
Multi-Analyte Data AnalysisReduces False Positives in
Cystic Fibrosis
T Henry, J Marcy, D Shirazi, and S Berberich
Iowa Newborn Screening Program
March 3, 2016
1
![Page 2: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/2.jpg)
Multi-analyte data analysis• Cancer genomics
– MammaPrint breast cancer recurrence assay– Predicts risk for breast cancer recurrence based on gene
expression data from 70 target genes– Developed using unbiased gene selection based on patient
outcomes
2
![Page 3: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/3.jpg)
Multi-analyte analysis: Cystic Fibrosis
• Why can’t NBS steal a page from the cancer book?• Many NBS disorders are multi-system disorders
– CF: respiratory, pancreatic, hepatobiliary, reproductive, etc.
• Perhaps additional biomarkers can be found that improve discrimination of disease states
3
![Page 4: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/4.jpg)
Multi-analyte analysis: Cystic Fibrosis• Number of specimens: 27,961 (approx. 9 mos)• Confirmed CF Dx: 9• CRMS: 7• Carriers: 29• Total clinical cases: 45• Normals: 27, 916• Data points per specimen: 76 (demographic, facility,
analyte, etc)• Total dataset: 2,125,036
4
![Page 5: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/5.jpg)
Multi-analyte analysis: Cystic Fibrosis• Analysis performed using Partek Genomic Suite• Data median normalized• ANOVA performed across all analytes using CF
diagnosis as the comparator groups (confirmed CF versus CRMS/carriers)
• Analytes with a greater than 2-fold change and false discovery rate of p<0.05 used for unsupervised hierarchical clustering
5
![Page 6: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/6.jpg)
Multi-analyte analysis: Cystic Fibrosis
6
![Page 7: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/7.jpg)
Multi-analyte analysis: Cystic Fibrosis
normals
CRMS/carriers
confirmed CF[C8] Cit/arg IRT
7normalsconfirmed CF CRMS carriers
![Page 8: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/8.jpg)
Multi-analyte analysis: Cystic Fibrosis
• IRT + cit/arg + [C8] (dataset n=27,961):– Accurately stratified 8 of 9 confirmed CF cases (1 false
negative) from CRMS/carriers– Accurately stratified 7 of 7 CRMS from confirmed CF
cases– Accurately stratified 28 of 29 CF carriers from confirmed
CF cases– Misclassified 4 normals into CRMS/carrier group
• IRT/DNA: potentially less reflexed for DNA mutation, less for sweat testing (1 or 2 mutations forwarded)
8
![Page 9: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/9.jpg)
Multi-analyte analysis: Cystic Fibrosis
• What’s next:– Additional data being added to refine/improve CF
model training set– Pilot project with multi-analyte model run in
parallel with current CF screening algorithm
• Multi-analyte analysis is challenging but provides opportunities for discovery
9
![Page 10: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/10.jpg)
Multi-analyte: special populations
• Preterm, LBW, NICU
10
GA, weight, and gender variance scatterplot
GA HI
GA LO
![Page 11: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/11.jpg)
Multi-analyte: special populations
• Preterm, LBW, NICU
Sub-population at GA </= 33 weeks
11
GA LO
GA HI
![Page 12: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/12.jpg)
Multi-analyte: special populations
• Preterm, LBW, NICU
TPN
12
TPN NEG
TPN POS
![Page 13: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/13.jpg)
Multi-analyte: special populations• TPN signature (in progress)
13
TPN NEG
TPN POS
met
[C8]
/[C1
0]
[C0]
/[C1
6]
[C5]
/[C3
]
[C5]
phe/
tyr
[C18
:2]
arg
[C12
:1]
17-O
HP
![Page 14: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/14.jpg)
Conclusions
• Screening is for risk stratification• Multi-analyte data analysis improves risk
stratification for true CF cases and CRMS/carriers• Algorithms can be embedded in the laboratory to
reduce the number of cases forwarded to follow up• Existing analyte data may be leveraged to provide
improved screening risk stratification
14
![Page 15: Multi-Analyte Data Analysis Reduces False Positives in ......• CRMS: 7 • Carriers: 29 • Total clinical cases: 45 • Normals: 27, 916 • Data points per specimen: 76 (demographic,](https://reader036.vdocuments.us/reader036/viewer/2022071107/5fe1cd7cc5e44b345a374ab4/html5/thumbnails/15.jpg)
Acknowledgements
• Iowa Department of Public Health• University of Iowa Hospitals and Clinics• State Hygienic Laboratory at the
University of Iowa
15